|
⚲
|
| Keyboard |
| Hansen Paul R
✚
|
|
|---|---|
| CIK # | 0001850324 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001850324] | |
| 4 | [0001850324] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cancer Genetics Inc | |
| Hansen Paul R |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2023-01-17 | Grant | 4,032 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-10-17 | Grant | 7,653 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-07-18 | Grant | 4,335 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-04-18 | Grant | 3,640 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-03-30 | Grant | 43,478 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-01-18 | Grant | 2,862 | $1.31 | 3,749 |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-11-09 | Inherited | 6,783 | $0.00 | |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-08-19 | Buy | 20,000 | $2.35 | 47,000 |
|
Cancer Genetics Inc VYNT
Stock option (right to buy) · derivative
|
2021-03-30 | Grant | 13,015 | $0.00 | |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-03-30 | Other | 65,000 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-03-30 | Other | 592,548 |